These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1936 related items for PubMed ID: 8274294

  • 1. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
    McDonald VL, Dick KO, Malik N, Shoyab M.
    Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
    [Abstract] [Full Text] [Related]

  • 2. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 3. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
    Morinaga Y, Suzuki H, Takatsuki F, Akiyama Y, Taniyama T, Matsushima K, Onozaki K.
    J Immunol; 1989 Dec 01; 143(11):3538-42. PubMed ID: 2584706
    [Abstract] [Full Text] [Related]

  • 4. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
    Lu C, Rak JW, Kobayashi H, Kerbel RS.
    Cancer Res; 1993 Jun 15; 53(12):2708-11. PubMed ID: 8504408
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 6. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
    Brown TJ, Lioubin MN, Marquardt H.
    J Immunol; 1987 Nov 01; 139(9):2977-83. PubMed ID: 3117884
    [Abstract] [Full Text] [Related]

  • 7. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999 Nov 01; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

  • 8. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S, Suzuki E, Ueda H, Makishima F.
    Cytokine; 1996 Dec 01; 8(12):889-94. PubMed ID: 9050746
    [Abstract] [Full Text] [Related]

  • 9. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
    Silvani A, Ferrari G, Paonessa G, Toniatti C, Parmiani G, Colombo MP.
    Cancer Res; 1995 May 15; 55(10):2200-5. PubMed ID: 7743524
    [Abstract] [Full Text] [Related]

  • 11. IL-6 signals inhibition of cell adhesion in melanoma A375-C6.
    Schwabe M, Deryugina EI, Bosco MC, Gusella GL, Reinisch W, Kung HF, Bourdon MA.
    Anticancer Res; 1996 May 15; 16(6B):3363-70. PubMed ID: 9042193
    [Abstract] [Full Text] [Related]

  • 12. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
    Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ.
    J Immunol; 1985 Dec 15; 135(6):3962-8. PubMed ID: 2415593
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts.
    Richards CD, Langdon C, Botelho F, Brown TJ, Agro A.
    J Immunol; 1996 Jan 01; 156(1):343-9. PubMed ID: 8598483
    [Abstract] [Full Text] [Related]

  • 15. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
    Schwabe M, Cox GW, Bosco MC, Prohaska R, Kung HF.
    Cell Immunol; 1996 Feb 25; 168(1):117-21. PubMed ID: 8599834
    [Abstract] [Full Text] [Related]

  • 16. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375.
    Hattori T, Hayashi H, Chiba T, Onozaki K.
    Eur Cytokine Netw; 2001 Feb 25; 12(2):244-52. PubMed ID: 11399512
    [Abstract] [Full Text] [Related]

  • 17. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.
    Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F, Harb J.
    Cytokine; 1995 Feb 25; 7(2):111-7. PubMed ID: 7780030
    [Abstract] [Full Text] [Related]

  • 18. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
    Radka SF, Nakamura S, Sakurada S, Salahuddin SZ.
    J Immunol; 1993 Jun 01; 150(11):5195-201. PubMed ID: 8098726
    [Abstract] [Full Text] [Related]

  • 19. Oncostatin M inhibits decidualization of normal human endometrial stromal cells.
    Tanaka T, Umesaki N.
    Int J Mol Med; 2003 May 01; 11(5):627-30. PubMed ID: 12684701
    [Abstract] [Full Text] [Related]

  • 20. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
    Liu J, Clegg CH, Shoyab M.
    Cell Growth Differ; 1992 May 01; 3(5):307-13. PubMed ID: 1633113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.